ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

FDA recall notice · announced November 29, 2023 · Actipharma

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

Reason for recall

FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

Notes

Distribution: Domestic distribution, in Puerto Rico.
Lot/code information: Lot 13309, Exp: 01/26
Quantity: 607 bottles of 100 tablets each
Status: Terminated
Products in this recall event:
- ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104. (F-0463-2024)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.